The company has a diversified drug portfolio within the field of pharmaceutical regenerative medicine. The portfolio contains three main products. TikoMeds business concept is to develop a drug portfolio up to a “Proof of Concept” stage in preclinical and up to early clinical studies. TikoMed will then use its board and management network and expertise to make value-generating deals with established Big Pharma players who will bring products to the patients.
- Bli medlem
- Om SwedenBIO